Dow Jones

39,118.86

-0.12%

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Essa Pharma (EPI)

Essa Pharma Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:TSXV:EPI

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
25/02/2021	23:33	PR Newswire (Canada)	ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders	TSXV:EPI	Essa Pharma Inc
13/01/2021	12:00	PR Newswire (Canada)	ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castr...	TSXV:EPI	Essa Pharma Inc
15/12/2020	22:01	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 20...	TSXV:EPI	Essa Pharma Inc
25/11/2020	12:00	PR Newswire (Canada)	ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference	TSXV:EPI	Essa Pharma Inc
26/10/2020	21:01	PR Newswire (Canada)	ESSA Pharma Inc. Announces Delisting from the TSX-V	TSXV:EPI	Essa Pharma Inc
25/10/2020	00:18	PR Newswire (Canada)	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium	TSXV:EPI	Essa Pharma Inc
19/10/2020	12:00	PR Newswire (Canada)	ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia	TSXV:EPI	Essa Pharma Inc
21/09/2020	12:00	PR Newswire (Canada)	ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit	TSXV:EPI	Essa Pharma Inc
17/09/2020	22:05	PR Newswire (Canada)	ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020	TSXV:EPI	Essa Pharma Inc
14/09/2020	12:00	PR Newswire (Canada)	ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resist...	TSXV:EPI	Essa Pharma Inc
10/09/2020	12:00	PR Newswire (Canada)	ESSA Pharma to Participate in Multiple Upcoming Investor Conferences	TSXV:EPI	Essa Pharma Inc
07/08/2020	01:00	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2020	TSXV:EPI	Essa Pharma Inc
31/07/2020	15:16	PR Newswire (Canada)	ESSA Pharma Completes Public Offering for Aggregate Gross Proceeds of US$48,990,000	TSXV:EPI	Essa Pharma Inc
29/07/2020	14:07	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - EPI	TSXV:EPI	Essa Pharma Inc
29/07/2020	14:05	PR Newswire (Canada)	IIROC Trading Resumption - EPI	TSXV:EPI	Essa Pharma Inc
29/07/2020	02:18	PR Newswire (Canada)	ESSA Pharma Announces Pricing of Public Offering of Common Shares	TSXV:EPI	Essa Pharma Inc
28/07/2020	21:03	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - EPI	TSXV:EPI	Essa Pharma Inc
28/07/2020	21:01	PR Newswire (Canada)	ESSA Pharma Announces Proposed Public Offering of Common Shares	TSXV:EPI	Essa Pharma Inc
28/07/2020	21:01	PR Newswire (Canada)	IIROC Trading Halt - EPI	TSXV:EPI	Essa Pharma Inc
15/07/2020	12:00	PR Newswire (Canada)	ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical Trial of EPI-7386 for Metastatic Castration-Resistant Prostra...	TSXV:EPI	Essa Pharma Inc
22/06/2020	12:30	PR Newswire (Canada)	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Me...	TSXV:EPI	Essa Pharma Inc
27/05/2020	12:00	PR Newswire (Canada)	ESSA Pharma to Present at Jefferies Virtual Healthcare Conference	TSXV:EPI	Essa Pharma Inc
15/05/2020	12:30	PR Newswire (Canada)	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual Meeting	TSXV:EPI	Essa Pharma Inc
07/05/2020	22:05	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020	TSXV:EPI	Essa Pharma Inc
30/04/2020	22:45	PR Newswire (Canada)	ESSA Pharma Announces FDA Allowance of the Clinical Investigation of EPI-7386 in Prostate Cancer	TSXV:EPI	Essa Pharma Inc
13/04/2020	23:08	PR Newswire (Canada)	ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement	TSXV:EPI	Essa Pharma Inc
31/03/2020	12:00	PR Newswire (Canada)	ESSA Pharma Submits IND for EPI-7386 for Prostate Cancer and Provides Business Update	TSXV:EPI	Essa Pharma Inc
28/02/2020	00:51	PR Newswire (Canada)	ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders	TSXV:EPI	Essa Pharma Inc
13/02/2020	22:48	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2019	TSXV:EPI	Essa Pharma Inc
10/02/2020	23:15	PR Newswire (Canada)	ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia	TSXV:EPI	Essa Pharma Inc